These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 31882290)
1. Influence of Ethnicity on Clinical Presentation and Quality of Life in Women With Uterine Fibroids: Results From a Prospective Observational Registry. Murji A; Bedaiwy M; Singh SS; Bougie O; J Obstet Gynaecol Can; 2020 Jun; 42(6):726-733.e1. PubMed ID: 31882290 [TBL] [Abstract][Full Text] [Related]
2. Role of ethnicity in treating uterine fibroids with ulipristal acetate. Murji A; Crosier R; Chow T; Ye XY; Shirreff L Fertil Steril; 2016 Oct; 106(5):1165-1169. PubMed ID: 27336213 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials. Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281 [TBL] [Abstract][Full Text] [Related]
4. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950 [TBL] [Abstract][Full Text] [Related]
5. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design. Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955 [TBL] [Abstract][Full Text] [Related]
6. A systematic review of the psychosocial impact of fibroids before and after treatment. Go VAA; Thomas MC; Singh B; Prenatt S; Sims H; Blanck JF; Segars JH Am J Obstet Gynecol; 2020 Nov; 223(5):674-708.e8. PubMed ID: 32474012 [TBL] [Abstract][Full Text] [Related]
7. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry. Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093 [TBL] [Abstract][Full Text] [Related]
8. Impact of uterine fibroids on quality of life: a national cross-sectional survey. Hervé F; Katty A; Isabelle Q; Céline S Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225 [TBL] [Abstract][Full Text] [Related]
10. One year symptom severity and health-related quality of life changes among Black African patients undergoing uterine fibroid embolisation. Mariara C; Obura T; Hacking N; Stones W BMC Res Notes; 2017 Jul; 10(1):240. PubMed ID: 28676073 [TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids. Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594 [TBL] [Abstract][Full Text] [Related]
12. Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy. Moorman PG; Leppert P; Myers ER; Wang F Fertil Steril; 2013 Mar; 99(3):768-776.e1. PubMed ID: 23199610 [TBL] [Abstract][Full Text] [Related]
13. The association between self-reported major life events and the presence of uterine fibroids. Vines AI; Ta M; Esserman DA Womens Health Issues; 2010; 20(4):294-8. PubMed ID: 20627775 [TBL] [Abstract][Full Text] [Related]
14. Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire: a Chinese translation and validation study. Yeung SY; Kwok JWK; Law SM; Chung JPW; Chan SSC Hong Kong Med J; 2019 Dec; 25(6):453-459. PubMed ID: 31796639 [TBL] [Abstract][Full Text] [Related]
15. Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary. Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A J Comp Eff Res; 2024 Aug; 13(8):e230194. PubMed ID: 38934918 [TBL] [Abstract][Full Text] [Related]
16. Growth of uterine leiomyomata among premenopausal black and white women. Peddada SD; Laughlin SK; Miner K; Guyon JP; Haneke K; Vahdat HL; Semelka RC; Kowalik A; Armao D; Davis B; Baird DD Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19887-92. PubMed ID: 19047643 [TBL] [Abstract][Full Text] [Related]
17. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014. Yu O; Scholes D; Schulze-Rath R; Grafton J; Hansen K; Reed SD Am J Obstet Gynecol; 2018 Dec; 219(6):591.e1-591.e8. PubMed ID: 30291840 [TBL] [Abstract][Full Text] [Related]
18. The impact of fibroid treatments on quality of life and mental health: a systematic review. Neumann B; Singh B; Brennan J; Blanck J; Segars JH Fertil Steril; 2024 Mar; 121(3):400-425. PubMed ID: 38246400 [TBL] [Abstract][Full Text] [Related]
19. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey). Koga K; Fukui M; Fujisawa M; Suzukamo Y J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334 [TBL] [Abstract][Full Text] [Related]
20. The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life. Pron G; Cohen M; Soucie J; Garvin G; Vanderburgh L; Bell S; Fertil Steril; 2003 Jan; 79(1):112-9. PubMed ID: 12524073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]